Adverse Effects of GLP-1 Receptor Agonists

The review of diabetic studies : RDS

Volumn 11, Issue 3-4, 2014, Pages 202-230

  Filippatos, Theodosios D ^a   Panagiotopoulou, Thalia V ^a   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

AGONISTS; ANIMAL; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; PANCREATITIS;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GASTROINTESTINAL DISEASES; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY DISEASES; PANCREATITIS;

EID: 84973429706     PISSN: None     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2014.11.202     Document Type: Review

References (0)